Rankings
▼
Calendar
VTRS Q3 2018 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$16B
Q3 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2.9B
-4.2% YoY
Gross Profit
$1.0B
36.3% margin
Operating Income
$338M
11.8% margin
Net Income
$177M
6.2% margin
EPS (Diluted)
$0.34
QoQ Revenue Growth
+1.9%
Cash Flow
Operating Cash Flow
$654M
Free Cash Flow
$592M
Stock-Based Comp.
-$27M
Balance Sheet
Total Assets
$33.5B
Total Liabilities
$21.4B
Stockholders' Equity
$12.1B
Cash & Equivalents
$449M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.9B
$3.0B
-4.2%
Gross Profit
$1.0B
$1.2B
-11.8%
Operating Income
$338M
$317M
+6.9%
Net Income
$177M
$88M
+100.1%
← FY 2018
All Quarters
Q4 2018 →